advertisement
11.14 Investigational drugs; pharmacological experiments (22)
Showing records 1 to 22
Display all abstracts in classification 11.14 Investigational drugs; pharmacological experiments
Search within classification 11.14 Investigational drugs; pharmacological experiments47577 Reduction of ER stress via a chemical chaperone prevents disease phenotypes in a mouse model of primary open angle glaucoma
Zode GS; Kuehn MH; Nishimura DY; Searby CC; Mohan K; Grozdanic SD; Bugge K; Anderson MG; Clark AF; Stone EM
Journal of Clinical Investigation 2011; 121: 3542-3553
48136 Egr1 expression is induced following glatiramer acetate immunotherapy in rodent models of glaucoma and Alzheimer's disease
Bakalash S; Pham M; Koronyo Y; Salumbides BC; Kramerov A; Seidenberg H; Berel D; Black KL; Koronyo-Hamaoui M
Investigative Ophthalmology and Visual Science 2011; 52: 9033-9046
47581 Indirect sympatholytic actions at (beta)-adrenoceptors account for the ocular hypotensive actions of cannabinoid receptor agonists
Hudson BD; Beazley M; Szczesniak A-M; Straiker A; Kelly MEM
Journal of Pharmacology and Experimental Therapeutics 2011; 339: 757-767
48001 Effect of recombinant human erythropoietin on bcl-2 protein expression in the retina in a rabbit model of acute high intraocular pressure
Wang JM; Song YP; Sun NX; Hui N; Zhao SP; Hu K
Journal of Southern Medical University 2010; 30: 552-554
47924 Tafluprost for glaucoma
Papadia M; Bagnis A; Scotto R; Traverso CE
Expert Opinion in Pharmacotherapy 2011; 12: 2393-2401
47679 The role of neurotrophins and mimetics in the treatment of ocular diseases
Bai Y; Ge J; Saragovi HU; Zhuo Y
Drugs of the Future 2011; 36: 123-131
48421 Simvastatin upregulates Bcl-2 expression and protects retinal neurons from early ischemia/reperfusion injury in the rat retina
Ko ML; Chen CF; Peng PH; Peng YH
Experimental Eye Research 2011; 93: 580-585
48338 Down-regulation of matrix metalloproteinase-9 by pyrrolidine dithiocarbamate prevented retinal ganglion cell death after transection of optic nerve in rats
Sun MH; Chen KJ; Tsao YP; Kao LY; Han WH; Lin KK; Pang JH
Current Eye Research 2011; 36: 1053-1063
48260 Neuroprotective effects of tempol acyl esters against retinal ganglion cell death in a rat partial optic nerve crush model
Thaler S; Fiedorowicz M; Grieb P; Wypych Z; Knap N; Borowik T; Zawada K; Kaminski J; Wozniak M; Rejdak R
Acta Ophthalmologica 2011; 89: 555-560
47600 Cannabinoids and their possible use in the treatment of glaucoma
Aldana BZ; Rodriguez IM; Pineda NT
Revista Cubana de Farmacia 2011; 45: 439-448
47596 Effect of Ketorolac Add-On Treatment on Intra-Ocular Pressure in Glaucoma Patients Receiving Prostaglandin Analogues
Turan-Vural E; Torun-Acar B; Acar S
Ophthalmologica 2011;
47896 Adenosine receptor targeting in health and disease
Gessi S; Merighi S; Fazzi D; Stefanelli A; Varani K; Borea PA
Expert Opinion on Investigational Drugs 2011; 20: 1591-1609
47824 Pharmacokinetics of pirfenidone after topical administration in rabbit eye
Sun G; Lin X; Zhong H; Yang Y; Qiu X; Ye C; Wu K; Yu M
Molecular Vision 2011; 17: 2191-2196
47678 Novel therapeutic approaches for glaucoma
Rasmussen CA; Kaufman PL
Drugs of the Future 2011; 36: 287-300
48329 Effects of Y-39983, a selective Rho-associated protein kinase inhibitor, on blood flow in optic nerve head in rabbits and axonal regeneration of retinal ganglion cells in rats
Tokushige H; Waki M; Takayama Y; Tanihara H
Current Eye Research 2011; 36: 964-970
47664 Ocular and systemic distribution of ino-8875, a selective adenosine A1 receptor agonist, in rabbits by quantitative whole body autoradiography (QWBA) and tissue analysis
Prescott E; Struble C; Denissen J; Kim N
Drug Metabolism Reviews 2011; 43: 78-79
48242 Efficacy and tolerability of topical 0 0.5% flunarizine in patients with open-angle glaucoma or ocular hypertension-a pilot study
Mansouri K; Silva SE; Shaarawy T
Journal of Glaucoma 2011; 20: 519-522
48283 Ocular hypotensive activity of BOL-303259-X, a nitric oxide donating prostaglandin F2α agonist, in preclinical models
Krauss AH; Impagnatiello F; Toris CB; Gale DC; Prasanna G; Borghi V; Chiroli V; Chong WK; Carreiro ST; Ongini E
Experimental Eye Research 2011; 93: 250-255
48323 Similar hydrodynamic and morphological changes in the aqueous humor outflow pathway after washout and Y27632 treatment in monkey eyes
Lu Z; Zhang Y; Freddo TF; Gong H
Experimental Eye Research 2011; 93: 397-404
47580 Effect of ion pairing on in vitro transcorneal permeability of a (Delta)(9)-tetrahydrocannabinol prodrug: Potential in glaucoma therapy
Hingorani T; Gul W; Elsohly M; Repka MA; Majumdar S
Journal of Pharmaceutical Sciences 2011;
48334 Evaluation of Sustained Release of PLC-Loaded Prednisolone Acetate Microfilm on Postoperative Inflammation in an Experimental Model of Glaucoma Filtration Surgery
Ang M; Yan P; Zhen M; Foo S; Venkatraman SS; Wong TT
Current Eye Research 2011; 36: 1123-1128
47803 Prevention of ocular scarring after glaucoma filtering surgery using the monoclonal antibody LT1009 (Sonepcizumab) in a rabbit model
Lukowski ZL; Min J; Beattie AR; Meyers CA; Levine MA; Stoller G; Schultz GS; Samuelson DA; Sherwood MB
Journal of Glaucoma 2011;